poisar

Stocks · News reference

8-K filing — enGene Therapeutics Inc. (ENGNW)

SEC EDGAR

Filed: 2026-09-08 AccNo: 0001193125-26-384380 Size: 419 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ENGNW
Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K/A filing — enGene Therapeutics Inc. (ENGNW)

    Filed: 2026-06-18 AccNo: 0001193125-26-275815 Size: 202 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    ENGNW